Literature DB >> 20870371

Acute liver injury after intravenous amiodarone: a case report.

Andrea Verhovez1, Fabrizio Elia, Alessandra Riva, Giovanni Ferrari, Franco Aprà.   

Abstract

Acute hepatotoxicity is a rare but potentially fatal complication of amiodarone use. Although oral long-term use of the drug is frequently complicated by an asymptomatic rise in serum aminotransferase concentrations, acute hepatotoxicity during intravenous loading is much less frequent and potentially fatal. We report a case of liver injury after intravenous administration in a patient with atrial fibrillation.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20870371     DOI： 10.1016/j.ajem.2010.03.035

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


  3 in total

1.  Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone.

Authors:  Jun-Hong Ye; Yunn-Fang Ho; Angela W-F On; Wen-Wen Chen; Yen-Ming Huang; Wei-I Huang; Yun-Wen Tang
Journal:  Int J Clin Pharm       Date:  2018-07-26

2.  Emerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models.

Authors:  Rita Roque Bravo; Helena Carmo; João Pedro Silva; Maria João Valente; Félix Carvalho; Maria de Lourdes Bastos; Diana Dias da Silva
Journal:  Arch Toxicol       Date:  2019-12-14       Impact factor: 5.153

3.  Predictors of intravenous amiodarone induced liver injury.

Authors:  O A Diab; John Kamel; Ahmed Adel Abd-Elhamid
Journal:  Egypt Heart J       Date:  2016-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.